January 9, 2024 - Page 4 of 10

NYSE Companies - January 9, 2024

Mohawk Industries, Inc. nodigt u uit om deel te nemen aan de conferencecall over de resultaten voor het vierde kwartaal van 2023

CALHOUN, Ga., Jan. 09, 2024 (GLOBE NEWSWIRE) — Naar aanleiding van de bekendmaking van de resultaten van Mohawk Industries, Inc. […]

Canadian Stock Exchange News - January 9, 2024

Nextech3D.AI Expanding AI Patent Portfolio and Announces Six New 3D Modeling Contracts & Renewals

TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) — via IBN — Nextech3D.AI (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS), an AI-3D model supplier […]

NASDAQ Companies - January 9, 2024

Virtu Financial Launches Sixth Annual Women’s Winternship Program

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) — Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of global, multi-asset financial services […]

NASDAQ Companies - January 9, 2024

Roma Green Finance Limited Announces Pricing of $12,300,000 Public Offering

HONG KONG, Jan. 09, 2024 (GLOBE NEWSWIRE) — Roma Green Finance Limited (Nasdaq: ROMA) (the “Company”), a Cayman Islands exempted […]

NASDAQ Companies - January 9, 2024

Exela Technologies Recognized as a Disruptor in Avasant Research Report

IRVING, Texas, Jan. 09, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global […]

TSX Venture News - January 9, 2024

NEO Battery Materials Provides Letter to Shareholders – 2024 Strategy & Outlook

TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) — (TSXV: NBM) (OTCQB: NBMFF) NEO Battery Materials Ltd. (“NEO” or the “Company”), a […]

NYSE Companies - January 9, 2024

TEN Ltd. Declares Dividend on its Series F Cumulative Redeemable Perpetual Preferred Shares

ATHENS, Greece, Jan. 09, 2024 (GLOBE NEWSWIRE) — TEN Ltd. (“TEN”) (NYSE: TNP) (the “Company”), a leading diversified crude, product […]

NASDAQ Companies - January 9, 2024

Kymera Therapeutics Outlines Key 2024 Objectives and Strategy to Progress Leading Portfolio of Immunology and Oncology Programs

IRAK4 oral degrader KT-474 (SAR444656) expected to complete enrollment in both Phase 2 HS and AD studies in fourth quarter […]

NASDAQ Companies - January 9, 2024

Kymera Therapeutics Announces Closing of Upsized $275 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

WATERTOWN, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new […]

NYSE Companies - January 9, 2024

Axalta Schedules Fourth-Quarter and Full-Year 2023 Earnings Conference Call

GLEN MILLS, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) — Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will […]